NAFLD - A rising metabolic disease

Mol Metab. 2021 Aug:50:101274. doi: 10.1016/j.molmet.2021.101274. Epub 2021 Jul 2.

Author

Anja Zeigerer¹

Affiliation

¹ Institute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: anja.zeigerer@helmholtz-muenchen.de.

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Disease Models, Animal
Humans
Liver / pathology*
Metabolic Diseases / drug therapy
Metabolic Diseases / metabolism*
Metabolic Diseases / pathology
Non-alcoholic Fatty Liver Disease / drug therapy
Non-alcoholic Fatty Liver Disease / metabolism*
Non-alcoholic Fatty Liver Disease / pathology